Last reviewed · How we verify

Belladonna and Opium Suppositories

Kristina A. Butler · FDA-approved active Small molecule

Belladonna and Opium Suppositories is a Anticholinergic/opioid combination Small molecule drug developed by Kristina A. Butler. It is currently FDA-approved for Rectal pain and spasm, Hemorrhoids, Post-anal surgical pain. Also known as: B & O Supprettes.

Belladonna alkaloids block muscarinic cholinergic receptors to reduce smooth muscle spasms, while opium alkaloids activate opioid receptors to provide analgesia and further reduce intestinal motility.

Belladonna alkaloids block muscarinic cholinergic receptors to reduce smooth muscle spasms, while opium alkaloids activate opioid receptors to provide analgesia and further reduce intestinal motility. Used for Rectal pain and spasm, Hemorrhoids, Post-anal surgical pain.

At a glance

Generic nameBelladonna and Opium Suppositories
Also known asB & O Supprettes
SponsorKristina A. Butler
Drug classAnticholinergic/opioid combination
TargetMuscarinic acetylcholine receptors; mu opioid receptors
ModalitySmall molecule
Therapeutic areaGastroenterology
PhaseFDA-approved

Mechanism of action

Belladonna (atropine and related tropane alkaloids) acts as an anticholinergic agent, inhibiting parasympathetic nervous system activity to relax smooth muscle in the gastrointestinal tract and reduce spasms. Opium alkaloids (primarily morphine and codeine) bind to mu and other opioid receptors in the central and peripheral nervous system, providing pain relief and reducing intestinal secretions and motility. Together, these agents address both pain and spasm associated with rectal and anal conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Belladonna and Opium Suppositories

What is Belladonna and Opium Suppositories?

Belladonna and Opium Suppositories is a Anticholinergic/opioid combination drug developed by Kristina A. Butler, indicated for Rectal pain and spasm, Hemorrhoids, Post-anal surgical pain.

How does Belladonna and Opium Suppositories work?

Belladonna alkaloids block muscarinic cholinergic receptors to reduce smooth muscle spasms, while opium alkaloids activate opioid receptors to provide analgesia and further reduce intestinal motility.

What is Belladonna and Opium Suppositories used for?

Belladonna and Opium Suppositories is indicated for Rectal pain and spasm, Hemorrhoids, Post-anal surgical pain.

Who makes Belladonna and Opium Suppositories?

Belladonna and Opium Suppositories is developed and marketed by Kristina A. Butler (see full Kristina A. Butler pipeline at /company/kristina-a-butler).

Is Belladonna and Opium Suppositories also known as anything else?

Belladonna and Opium Suppositories is also known as B & O Supprettes.

What drug class is Belladonna and Opium Suppositories in?

Belladonna and Opium Suppositories belongs to the Anticholinergic/opioid combination class. See all Anticholinergic/opioid combination drugs at /class/anticholinergic-opioid-combination.

What development phase is Belladonna and Opium Suppositories in?

Belladonna and Opium Suppositories is FDA-approved (marketed).

What are the side effects of Belladonna and Opium Suppositories?

Common side effects of Belladonna and Opium Suppositories include Dry mouth, Constipation, Drowsiness, Dizziness, Urinary retention.

What does Belladonna and Opium Suppositories target?

Belladonna and Opium Suppositories targets Muscarinic acetylcholine receptors; mu opioid receptors and is a Anticholinergic/opioid combination.

Related